Vyro Bio is pioneering a novel class of tumor-directed oncolytic immunotherapies for malignant central nervous system (CNS) tumors, both pediatric and adult. Our focus is to revolutionize the treatment of these tumors through the development of oncolytic viruses (OVs) based on the properties of the Zika virus. A Vyro é pioneira em uma nova classe de imunoterapias direcionadas a tumores malignos do sistema nervoso central (SNC), tanto pediátricos quanto adultos. O foco é a revolução do tratamento desses tumores através do desenvolvimento de vírus oncolíticos baseados nas propriedades do Zika vírus.
| Website | https://www.vyrobio.com/ |
| Employees | 8 (3 on RocketReach) |
| Founded | 2021 |
| Phone | +55 11 99311-4939 |
| Industry | Biotechnology |
| Keywords | Oncolytic Viruses, Pediatric Brain Cancer, Neuro-Oncology, Brain Tumor Treatment, Immunotherapeutic Agents, Immunotherapy Research, Oncology Research, Novel Cancer Therapies, Cancer Treatment, Cancer Immunology, Drug Development, Cancer Research, Pharmaceutical Research, Clinical Stage Biotech, Biotechnology |
| Competitors | BASF, Evonik, Novozymes, Amyris, LanzaTech, Geno, Zymergen, Inc., ZymoChem, Calysta, Handary S.A. +38 more (view full list) |
Looking for a particular VYROBIO employee's phone or email?
VYROBIO Questions
3 people are employed at VYROBIO.
Top VYROBIO Employees
-
Natan Siegel
Manufacturing Manager at VYROBIO
Brasília, DF, BR31 -
Marcos Alexandre Nobre Lemos
Pesquisador sênior at VYROBIO
São Paulo, SP, BR2 -
Fabiane dos Santos Honório
Técnico de laboratório at VYROBIO
State of São Paulo, Brazil1
Related Companies
